Discuss the institutional and legal framework governing psychotropic substance control in India. How do agencies like the Central Bureau of Narcotics contribute to countering the narco-terror nexus?

Q. Discuss the institutional and legal framework governing psychotropic substance control in India. How do agencies like the Central Bureau of Narcotics contribute to countering the narco-terror nexus? (15 marks, 250-350 words)

The Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985 is the cornerstone of India's drug control architecture, criminalising the production, trade and export of controlled substances while enabling their licit medical and scientific use [2]. Recent seizures of diverted synthetic opioids show that this framework is being tested by transnational trafficking networks.

Legal framework - NDPS Act, 1985 prohibits dealings in narcotic drugs and psychotropic substances; Section 8(c) restricts their export, making unauthorised outbound consignments punishable [2]. - The Act's schedules are dynamic — Tramadol, a synthetic opioid, was notified as a psychotropic substance in 2018, bringing its manufacture, sale and export under statutory control. - India's obligations under the UN Single Convention on Narcotic Drugs, 1961, monitored by the International Narcotics Control Board (INCB), shape domestic scheduling and export-verification duties [1].

Institutional framework - Central Bureau of Narcotics (CBN), Gwalior, under the Department of Revenue, Ministry of Finance, licenses opium cultivation and regulates licit manufacture and export of controlled drugs [3]. - Narcotics Control Bureau (MHA) coordinates enforcement; the Directorate of Revenue Intelligence and Customs guard EXIM channels; State police act at the ground level. - Coordination is the operative principle: in "Operation Vajra" (July 2026), CBN Gwalior worked with DRI Bengaluru and Kochi to seize 12 crore Tramadol tablets (~30 metric tons) from a Delhi warehouse, arresting three persons [1].

Countering the narco-terror nexus - CBN's risk-based export control mechanism flagged the consignment; verification with INCB and Guinea-Bissau authorities exposed a false declaration masking diversion to Libya [1]. - Tramadol is dubbed the "fighter drug" after reported use by ISIS combatants — interdiction thus denies conflict actors both a stimulant and a financing stream [1]. - Such action protects India's credibility as a pharmaceutical export hub against misuse of legitimate trade documentation [1].

The framework is sound in law; its weak link is scale of oversight over pharmaceutical exports. Strengthening end-use verification, digitised consignment tracking and CBN's manpower — alongside deeper INCB and destination-country cooperation — would align enforcement with SDG 16's call to combat organised crime and secure both public health and national security.

(~330 words)

Sources: 1. PIB, "Central Bureau of Narcotics (CBN) India thwarts illegal trafficking of 12 crore Tramadol Hydrochloride, a.k.a. 'fighter drug' tablets under Operation Vajra" (2026) — seizure scale, Delhi warehouse, arrests, DRI/INCB coordination, Guinea-Bissau–Libya diversion, "fighter drug" tag 2. The Narcotic Drugs and Psychotropic Substances Act, 1985, Department of Revenue, Ministry of Finance — statutory prohibition and Section 8(c) export restriction 3. Department of Revenue, "Central Bureau of Narcotics" — CBN's parent department, headquarters and licensing/regulatory mandate